Risk factors of HIV and variation in access to clean needles among people who inject drugs in Pakistan

References

• Ahmed A, Hashmi FK, Khan GM. HIV outbreaks in Pakistan. Lancet HIV. 2019;6(7):e418.
   PubMedGoogle Scholar
• National AIDS Control Program. Integrated biological & behavioral surveillance in Pakistan 2005-2006 round 1. Islamabad, Pakistan: National Institute of Health; 2005.
   Google Scholar
• National AIDS Control Program. Integrated biological & behavioral surveillance in Pakistan 2016-17 round 5. Islamabad, Pakistan: National Institute of Health; 2017.
   Google Scholar
• National AIDS Control Program. Integrated biological & behavioral surveillance in Pakistan 2011 round 4. Islamabad, Pakistan: National Institute of Health; 2012.
   Google Scholar
• National AIDS Control Program. Integrated biological & behavioral surveillance in Pakistan 2006-2007 round 2. Islamabad, Pakistan: National Institute of Health; 2007.
   Google Scholar
• National AIDS Control Program. Integrated biological & behavioral surveillance in Pakistan 2008 round 3. Islamabad, Pakistan: National Institute of Health; 2008.
   Google Scholar
• Melesse DY, Shafer LA, Emmanuel F, et al. Heterogeneity in geographical trends of HIV epidemics among key populations in Pakistan: a mathematical modeling study of survey data. J Glob Health. 2018;8(1).
   PubMed Web of Science ®Google Scholar
• Reza T, Melesse DY, Shafer LA, et al. Patterns and trends in Pakistan’s heterogeneous HIV epidemic. Sex Transm Infect. 2013;89(Suppl 2):ii4–10. DOI:10.1136/sextrans-2012-050872
   PubMedGoogle Scholar
• Emmanuel F, Archibald C, Razaque A, et al. Factors associated with an explosive HIV Epidemic among injecting drug users in Sargodha, Pakistan. J Acquir Immune Defic Syndr. 2009;51(1):85–90.
   PubMed Web of Science ®Google Scholar
• Khan AA, Khan A. The HIV epidemic in Pakistan. J Pak Med Assoc. 2010 Dec;60(4):300–7.
   PubMedGoogle Scholar
• Altaf A. Delays and gaps in HIV programmes in Pakistan. Lancet HIV. 2018 Dec ;5(12):e678–9.
   PubMed Web of Science ®Google Scholar
• Mesquita F, Jacka D, Ricard D, et al. Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO). Harm Reduct J. 2008;5(1):26. DOI:10.1186/1477-7517-5-26
   PubMedGoogle Scholar
• Wodak A, McLeod L. The role of harm reduction in controlling HIV among injecting drug users. AIDS (London, England). 2008;2(Suppl 2):S81–92.
   Google Scholar
• Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41(6–7):777–813.
   PubMed Web of Science ®Google Scholar
• Platt L, Minozzi S, Reed J, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a cochrane review and meta-analysis. Addiction. 2018;113(3):545–563. DOI:10.1111/add.14012
   PubMed Web of Science ®Google Scholar
• UNAIDS. Country progress report - Pakistan (2018)
   Google Scholar
• Archibald CP, Shaw SY, Emmanuel F, et al. Geographical and temporal variation of injection drug users in Pakistan. Sex Transm Infect. 2013;89(Suppl 2):ii18–28. DOI:10.1136/sextrans-2012-050775
   PubMedGoogle Scholar
• StataCorp 2019. Stata statistical software: release 16. college station TSL. STATA statistical software. College Station, Texas: StataCorp LLC; 2019.
   Google Scholar
• Bergenstrom A, Achakzai B, Furqan S, et al. Drug-related HIV epidemic in Pakistan: a review of current situation and response and the way forward beyond 2015. Harm Reduct J. 2015;12(1). DOI:10.1186/s12954-015-0079-5
   PubMedGoogle Scholar
• Mir MU, Akhtar F, Zhang M, et al. A meta-analysis of the association between needle exchange programs and HIV seroconversion among injection drug users. Cureus. 2018;10(9): e3328-e. DOI:10.7759/cureus.3328
   Google Scholar
• Gibson DR, Hudes ES, Donovan D. Estimating and correcting for response bias in self‐reported HIV risk behavior. J Sex Res. 1999;36(1):96–101.
   Web of Science ®Google Scholar
• Farooq SA, Rasooly MH, Abidi SH, et al. Opium trade and the spread of HIV in the golden crescent. Harm Reduct J. 2017;14(1). DOI:10.1186/s12954-017-0170-1
   PubMedGoogle Scholar
• Kuo I, Ul-Hasan S, Galai N, et al. High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. Harm Reduct J. 2006;3(1):26. DOI:10.1186/1477-7517-3-26
   PubMedGoogle Scholar
• Altaf A, Zahidie A, Agha A. Comparing risk factors of HIV among hijra sex workers in Larkana and other cities of Pakistan: an analytical cross sectional study. BMC Public Health. 2012;12(1):279.
   PubMedGoogle Scholar
• Todd CS, Nasir A, Stanekzai M, et al. Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: a cross-sectional assessment. Harm Reduct J. 2011;8(1):22. DOI:10.1186/1477-7517-8-22
   PubMedGoogle Scholar
• Melesse DY, Shafer LA, Shaw SY, et al. Heterogeneity among sex workers in overlapping HIV risk interactions with people who inject drugs: a cross-sectional study from 8 major cities in Pakistan. Medicine (Baltimore). 2016;95(12): e3085-e. doi:10.1097/MD.0000000000003085.
   PubMed Web of Science ®Google Scholar
• Khan AA, Rehan N, Qayyum K, et al. Correlates and prevalence of HIV and sexually transmitted infections among Hijras (male transgenders) in Pakistan. Int J STD AIDS. 2008;19(12):817–820.
   PubMed Web of Science ®Google Scholar
• Yousaf MZ, Zia S, Babar ME, et al. The epidemic of HIV/AIDS in developing countries; the current scenario in Pakistan. Virol J. 2011;8(1):401.
   PubMedGoogle Scholar
• Shuper PA, Neuman M, Kanteres F, et al. Causal considerations on alcohol and HIV/AIDS – a systematic review. Alcohol Alcohol. 2010;45(2):159–166.
   PubMed Web of Science ®Google Scholar
• Baliunas D, Rehm J, Irving H, et al. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55(3):159–166.
   PubMed Web of Science ®Google Scholar
• Rai MA, Warraich HJ, Ali SH, et al. HIV/AIDS in Pakistan: the battle begins. Retrovirology. 2007;4(1):22.
   PubMedGoogle Scholar
• Pellowski JA, Kalichman SC, Matthews KA, et al. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol. 2013;68(4):197–209.
   PubMed Web of Science ®Google Scholar
• Asian Development Bank. Poverty In Pakistan, Basic Statistics 2020 [ Available from: https://www.adb.org/countries/pakistan/poverty.
   Google Scholar
• Emmanuel F, Fatima M. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed. Int J Drug Policy. 2008;19:59–64.
   PubMed Web of Science ®Google Scholar
• Asma B, Naseer MN, Denis JJ, et al. HIV risk in Karachi and Lahore, Pakistan: an emerging epidemic in injecting and commercial sex networks. Int J STD AIDS. 2007;18(7):486–492. DOI:10.1258/095646207781147201
   PubMed Web of Science ®Google Scholar
• Merkinaite S, Grund JP, Frimpong A. Young people and drugs: next generation of harm reduction. Int J Drug Policy. 2010;21(2):112–114.
   PubMed Web of Science ®Google Scholar
• Strathdee SA, Zafar T, Brahmbhatt H, et al. Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug Alcohol Dependence. 2003;71(1):17–24.
   PubMed Web of Science ®Google Scholar
• Haque N, Zafar T, Brahmbhatt H, et al. High-risk sexual behaviours among drug users in Pakistan: implications for prevention of STDs and HIV/AIDS. Int J STD AIDS. 2004;15(9):601–607.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drug and Crime. Female drug use in Pakistan. Pakistan; 2010 https://www.unodc.org/documents/pakistan/female_drugs_use.pdf
   Google Scholar
• Population Stat. Karachi, Pakistan population 2020 [ Available from: https://populationstat.com/pakistan/karachi.
   Google Scholar
• Altaf A, Janjua NZ, Kristensen S, et al. High-risk behaviours among juvenile prison inmates in Pakistan. Public Health. 2009;123(7):470–475. DOI:10.1016/j.puhe.2009.06.001
   PubMed Web of Science ®Google Scholar
• Kazi AM, Shah SA, Jenkins CA, et al. Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Inter J Infect Dis. 2010;14:e60–6.
   PubMed Web of Science ®Google Scholar
• Rueda S, Mitra S, Chen S, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7):e011453. DOI:10.1136/bmjopen-2016-011453
   PubMed Web of Science ®Google Scholar
• Noman R, Naeem Z, Zaman A, et al. Stigma and discrimination experienced by people living with HIV/AIDS at health care facilities in Karachi, Pakistan. SMU Med J. 2015;2:127–138.
   Google Scholar
• Naseem Z, Ayub M, Shah SA, et al. Viral infections in Pakistan: prevalence, factors affecting spread, and recommendations for control. J Infect Developing Countries. 2022;16(06):913–926.
   Google Scholar
• Ali SA, Donahue RMJ, Qureshi H, et al. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Inter J Infect Dis. 2009;13(1):9–19.
   PubMed Web of Science ®Google Scholar